Caxton Associates (New York)’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,279
Closed -$1.28M 578
2023
Q4
$1.28M Hold
4,279
0.07% 192
2023
Q3
$1.17M Buy
+4,279
New +$1.23M 0.16% 123
2022
Q3
Sell
-7,616
Closed -$1.51M 663
2022
Q2
$1.51M Buy
+7,616
New +$1.79M 0.15% 59
2021
Q2
Sell
-898
Closed -$219K 605
2021
Q1
$219K Buy
+898
New +$215K 0.02% 357
2019
Q4
Sell
-26,307
Closed -$5.69M 544
2019
Q3
$5.69M Buy
+26,307
New +$5.64M 1.13% 11
2019
Q1
Sell
-1,612
Closed -$253K 484
2018
Q4
$253K Sell
1,612
-2,598
-62% -$435K 0.04% 209
2018
Q3
$748K Sell
4,210
-3,172
-43% -$541K 0.05% 177
2018
Q2
$1.25M Buy
+7,382
New +$1.24M 0.06% 143
2018
Q1
Sell
-9,185
Closed -$1.42M 427
2017
Q4
$1.42M Buy
9,185
+4,685
+104% +$715K 0.07% 164
2017
Q3
$639K Buy
+4,500
New +$645K 0.02% 254
2017
Q2
Sell
-4,600
Closed -$606K 563
2017
Q1
$606K Buy
+4,600
New +$581K ﹤0.01% 205

Other funds holding SYK

Caxton Associates (New York)'s SYK Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Stryker (SYK) in Q1 2024, closing a stake of 4,279 shares — an estimated $1.28M sold.

Caxton Associates (New York) first reported a position in SYK in Q1 2017 and held it in 11 quarters. The position peaked at $5.69M in Q3 2019. 1,991 funds tracked by Wall St. Rank hold SYK as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Stryker position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,279 Stryker shares in Q1 2024, an estimated $1.28M.
  • Caxton Associates (New York) first reported a position in Stryker in Q1 2017 and held it in 11 quarters.
  • Caxton Associates (New York)'s Stryker position peaked at $5.69M in Q3 2019.
  • 1,991 funds tracked by Wall St. Rank held Stryker as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.